default author photo

Badara Cisse

Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF)

SCHOLARLY PAPERS

1

DOWNLOADS

133

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Multi-Center, Observer-Blind, Randomized, Phase 3 Study to Evaluate Safety, Non-Inferiority of Multi-Dose and Single-Dose Vial Formulations of EuTCV (Vi-CRM197 Typhoid Conjugate Vaccine) and Lot-to-Lot Consistency of the Immune Response to Multi-Dose Vial Formulation EuTCV in Healthy Participants in Kenya and Senegal

Number of pages: 19 Posted: 24 Jan 2025
Birahim Pierre Ndiaye, Lucy Koech, Laina Mercer, John J. Aponte, Badara Cisse, Faith Riziki, Winnie Keter, Djibril Wade, Siry Diye, Niles Eaton, Emily Locke, Mike Raine, Fred Cassels, Rahsan Erdem, Gamou Fall, Moussa Dia, Ndeye S. Bob, Yeong Ok Baik, Chankyu Lee, Youngran Park, Soo Kyung Kim, Howard Lee Her and Patricia Njuguna
Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Kenya Medical Research Institute (KEMRI) - Kenya Medical Research Institute (KEMRI)/Walter Reed Project, Institute for Disease Modeling, PATH, Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), PATH, PATH, PATH, PATH, PATH, University of Paris-Saclay - Institut Pasteur, Institut Pasteur de Dakar, Institut Pasteur de Dakar, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center and World Health Organization (WHO) - Global Malaria Programme
Downloads 133 (547,695)

Abstract:

Loading...

Africa, Kenya, Senegal, EuTCV, Typhoid, adults, children, infants, conjugate vaccine, safety, immunogenicity, intramuscular.